Ronen D, Sherman L, Bar-Nun S, Teitz Y
Sackler School of Medicine, Tel Aviv University, Israel.
Antimicrob Agents Chemother. 1987 Nov;31(11):1798-802. doi: 10.1128/AAC.31.11.1798.
The mode of inhibition of N-methylisatin-beta-4',4'-diethylthiosemicarbazone (M-IBDET) on Moloney leukemia virus production was studied. Drug treatment of infected cells did not alter the amounts or sizes of the 35S and 22S subgenomic viral RNAs. The translation abilities of poly(A)+ RNA derived from M-IBDET-treated cells was also unaffected, as judged by cell-free translation analysis. Poly(A)+ RNA derived from M-IBDET-treated cells directed translation of equal amounts of viral gag precursors, gPr-80gag and Pr-65gag, as did poly(A)+ RNA prepared from untreated cells. The addition of M-IBDET to a cell-free translation system programmed with either total poly(A)+ RNA extracted from infected cells or hybrid-selected viral RNA inhibited the synthesis of viral protein precursors. An examination of the effect of M-IBDET on polysomes engaged in the translation of viral proteins revealed a fourfold accumulation of polysomal virus-specific RNA in drug-treated cells. These results suggest that the inhibition of Moloney leukemia virus by M-IBDET involves a block in the translation of viral RNA rather than interference with viral RNA transcription.
研究了N-甲基异靛红-β-4',4'-二乙硫代氨基脲(M-IBDET)对莫洛尼白血病病毒产生的抑制模式。用药物处理感染细胞不会改变35S和22S亚基因组病毒RNA的量或大小。通过无细胞翻译分析判断,来自M-IBDET处理细胞的聚腺苷酸(poly(A))+RNA的翻译能力也未受影响。来自M-IBDET处理细胞的聚腺苷酸(poly(A))+RNA指导合成等量的病毒gag前体、gPr-80gag和Pr-65gag,未处理细胞制备的聚腺苷酸(poly(A))+RNA也是如此。将M-IBDET添加到用从感染细胞中提取的总聚腺苷酸(poly(A))+RNA或杂交选择的病毒RNA编程的无细胞翻译系统中,会抑制病毒蛋白前体的合成。研究M-IBDET对参与病毒蛋白翻译的多核糖体的影响时发现,在药物处理的细胞中,多核糖体病毒特异性RNA积累了四倍。这些结果表明,M-IBDET对莫洛尼白血病病毒的抑制涉及病毒RNA翻译的阻断,而非对病毒RNA转录的干扰。